Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
Objective. The PleurX® IPC system has been used extensively in the past. Over time, management of MPE with the PleurX system can be costly. The new ASEPT pleural catheter, through advantages in design, may ultimately show cost savings. The primary outcome of this study was to evaluate safety and eff...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2016/4273480 |
id |
doaj-a3f7d0eb536f473789d9d27ad53b5b41 |
---|---|
record_format |
Article |
spelling |
doaj-a3f7d0eb536f473789d9d27ad53b5b412021-07-02T03:24:54ZengHindawi LimitedCanadian Respiratory Journal1198-22411916-72452016-01-01201610.1155/2016/42734804273480Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient SatisfactionInderdeep Dhaliwal0Masoud Mahdavian1Shabnam Asghari2Benson Chun To Wong3Rosalie Labelle4Kayvan Amjadi5Schulich School of Medicine, Western University, Victoria Hospital, London Health Sciences Centre, London, ON, CanadaDivision of Respirology, Faculty of Medicine, Memorial University of Newfoundland (MUN), St. John’s, NL, CanadaDiscipline of Family Medicine, Health Sciences Centre, Memorial University of Newfoundland (MUN), St. John’s, NL, CanadaDivision of Respirology, University of Ottawa, The Ottawa Hospital, Ottawa, ON, CanadaDepartment of Medicine, Division of Interventional Pulmonology, The Ottawa Hospital, Ottawa, ON, CanadaDivision of Interventional Pulmonology, University of Ottawa, The Ottawa Hospital, Ottawa, ON, CanadaObjective. The PleurX® IPC system has been used extensively in the past. Over time, management of MPE with the PleurX system can be costly. The new ASEPT pleural catheter, through advantages in design, may ultimately show cost savings. The primary outcome of this study was to evaluate safety and efficacy of the ASEPT system. Method. This single centre, prospective study enrolled 50 patients with MPE, who were followed for as long as they were alive with a catheter. Quality of Life (QoL) was assessed before, at 2 weeks, and 6 weeks after ASEPT catheter insertion using the EORTC QLQ-C30 and LC13 questionnaires. Ease of catheter use and complications were reported by physician and community nurses. Results. 50 patients with MPE with a mean age of 64.5±1.9, BDI of 2.8±0.9, and ECOG score of 3.0±0.7 were recruited. No immediate or long-term complications were reported during the study period. Compared to precatheter insertion, global health status (−18, p<0.001), QLQ-C30 dyspnea (−39, p<0.00001), and LC13 dyspnea (−11, p<0.0005) significantly improved at 2 and 6 weeks after intervention. Provider surveys indicated favourable ease of use. Conclusion. The new ASEPT catheter offers a safe and effective option for the management of MPE.http://dx.doi.org/10.1155/2016/4273480 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Inderdeep Dhaliwal Masoud Mahdavian Shabnam Asghari Benson Chun To Wong Rosalie Labelle Kayvan Amjadi |
spellingShingle |
Inderdeep Dhaliwal Masoud Mahdavian Shabnam Asghari Benson Chun To Wong Rosalie Labelle Kayvan Amjadi Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction Canadian Respiratory Journal |
author_facet |
Inderdeep Dhaliwal Masoud Mahdavian Shabnam Asghari Benson Chun To Wong Rosalie Labelle Kayvan Amjadi |
author_sort |
Inderdeep Dhaliwal |
title |
Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction |
title_short |
Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction |
title_full |
Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction |
title_fullStr |
Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction |
title_full_unstemmed |
Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction |
title_sort |
management of malignant pleural effusion with asept® pleural catheter: quality of life, feasibility, and patient satisfaction |
publisher |
Hindawi Limited |
series |
Canadian Respiratory Journal |
issn |
1198-2241 1916-7245 |
publishDate |
2016-01-01 |
description |
Objective. The PleurX® IPC system has been used extensively in the past. Over time, management of MPE with the PleurX system can be costly. The new ASEPT pleural catheter, through advantages in design, may ultimately show cost savings. The primary outcome of this study was to evaluate safety and efficacy of the ASEPT system. Method. This single centre, prospective study enrolled 50 patients with MPE, who were followed for as long as they were alive with a catheter. Quality of Life (QoL) was assessed before, at 2 weeks, and 6 weeks after ASEPT catheter insertion using the EORTC QLQ-C30 and LC13 questionnaires. Ease of catheter use and complications were reported by physician and community nurses. Results. 50 patients with MPE with a mean age of 64.5±1.9, BDI of 2.8±0.9, and ECOG score of 3.0±0.7 were recruited. No immediate or long-term complications were reported during the study period. Compared to precatheter insertion, global health status (−18, p<0.001), QLQ-C30 dyspnea (−39, p<0.00001), and LC13 dyspnea (−11, p<0.0005) significantly improved at 2 and 6 weeks after intervention. Provider surveys indicated favourable ease of use. Conclusion. The new ASEPT catheter offers a safe and effective option for the management of MPE. |
url |
http://dx.doi.org/10.1155/2016/4273480 |
work_keys_str_mv |
AT inderdeepdhaliwal managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction AT masoudmahdavian managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction AT shabnamasghari managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction AT bensonchuntowong managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction AT rosalielabelle managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction AT kayvanamjadi managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction |
_version_ |
1721341640224800768 |